Anomaly Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,252,086
Closed -$14.9M 39
2024
Q1
$14.9M Buy
+1,252,086
New +$13.9M 0.53% 28
2023
Q4
Sell
-2,902,264
Closed -$40.2M 38
2023
Q3
$40.2M Sell
2,902,264
-3,109,599
-52% -$45.5M 1.84% 22
2023
Q2
$72M Buy
6,011,863
+3,357,669
+127% +$37.9M 2.78% 16
2023
Q1
$31.1M Sell
2,654,194
-3,014,867
-53% -$44M 1.37% 24
2022
Q4
$95.5M Sell
5,669,061
-1,897,403
-25% -$31.3M 4.3% 9
2022
Q3
$88.4M Buy
7,566,464
+1,874,754
+33% +$26.8M 4.75% 8
2022
Q2
$89.7M Buy
+5,691,710
New +$95.6M 4.52% 10

Other funds holding PTEN

Anomaly Capital Management's PTEN Position: Q2 2024 in Review

Anomaly Capital Management sold out of Patterson-UTI (PTEN) in Q2 2024, closing a stake of 1,252,086 shares — an estimated $14.9M sold.

Anomaly Capital Management first reported a position in PTEN in Q2 2022 and held it in 7 quarters. The position peaked at $95.5M in Q4 2022. 358 funds tracked by Wall St. Rank hold PTEN as of Q2 2024.

  • Anomaly Capital Management reported no remaining Patterson-UTI position as of Q2 2024 after selling out during the quarter.
  • Anomaly Capital Management sold 1,252,086 Patterson-UTI shares in Q2 2024, an estimated $14.9M.
  • Anomaly Capital Management first reported a position in Patterson-UTI in Q2 2022 and held it in 7 quarters.
  • Anomaly Capital Management's Patterson-UTI position peaked at $95.5M in Q4 2022.
  • 358 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2024.

Based on Anomaly Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.